IP Verse

Microporous Zirconium Silicate And Diuretics For The Reduction Of Potassium And Treatment Of Chronic Kidney And/Or Chronic Heart Disease

Patent No. EP2981272 (titled "Microporous Zirconium Silicate And Diuretics For The Reduction Of Potassium And Treatment Of Chronic Kidney And/Or Chronic Heart Disease") was filed by ZS Pharma on Apr 3, 2014. The application was issued on Mar 1, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKDec 1, 2023ELKINGTON AND FIFE
TEVA PHARMACEUTICALSNov 22, 2023KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2981272

ZS PHARMA
Application Number
EP14779186A
Filing Date
Apr 3, 2014
Status
Revoked
Jun 27, 2025
Publication Date
Mar 1, 2023
External Links
Slate, Register , Google Patents